Rapid and Early Onset of Itch Relief with Tapinarof Cream 1% Once Daily in Two Pivotal Phase 3 Trials in Adults and Children Down to Two Years of Age with Atopic Dermatitis

Main Article Content

Eric Simpson
Jonathan I. Silverberg
Robert Bissonnette
Linda Stein Gold
April Armstrong
Adelaide A. Hebert
Rocco T. Serrao
Jeannette R. Jakus
Philip M. Brown
David S. Rubenstein
Stephen C. Piscitelli
Anna Tallman
a:1:{s:5:"en_US";s:9:"Dermavant";}

Lawrence F. Eichenfield

Keywords

atopic dermatitis, eczema, tapinarof cream 1% once daily, itch, pruritus, PP-NRS, AhR agonist

References

1. Silverberg JI, et al. Ann Allergy Asthma Immunol. 2018;121:340–347.

2. LeBovidge JS, et al. J Pediatr Psychol. 2007;32:617–625.

3. Meltzer LJ, et al. Ann Allergy Asthma Immunol. 2020;124:385–392.

4. Birdi G, et al. Int J Dermatol. 2020;59:e75–e91.

5. Dermavant Sciences. VTAMA (tapinarof) cream, 1%: US prescribing information. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215272s000lbl.pdf. Accessed September 2023.

6. Kircik L, et al. Poster at the Winter Clinical Dermatology Conference, January 13–18, 2023.

7. Peppers J, et al. J Am Acad Dermatol. 2019;80:89–98.

8. Paller AS, et al. J Am Acad Dermatol. 2021;84:632–638.

9. Silverberg JI, et al. Presentation at the European Academy of Dermatology and Venereology, October 11–14, 2023.

10. Yosipovitch G, et al. Br J Dermatol. 2019;181:761–769.

11. Blauvelt A, et al. J Eur Acad Dermatol Venereol. 2023;37:137–146.

12. Silverberg JI, et al. Br J Dermatol. 2020;183:891–898.

Article Sidebar

PDF
Published
Nov 13, 2023
DOI https://doi.org/10.25251/skin.7.supp.281

Article Details

How to Cite
Simpson, E., Silverberg, J. I., Bissonnette, R., Gold, L. S., Armstrong, A., Hebert, A. A., Serrao, R. T., Jakus, J. R., Brown, P. M., Rubenstein, D. S., Piscitelli, S. C., Tallman, A. ., & Eichenfield, L. F. (2023). Rapid and Early Onset of Itch Relief with Tapinarof Cream 1% Once Daily in Two Pivotal Phase 3 Trials in Adults and Children Down to Two Years of Age with Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, 7(6), s281. https://doi.org/10.25251/skin.7.supp.281
Issue
Vol. 7 No. 6 (2023): November 2023 Issue
Section
Atopic Dermatitis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>